Visible signs such as cloudiness, discoloration, or particles may indicate a problem
This uptick in cases is tied to persistent concerns about the medications side effects, with plaintiffs citing numerous health complications
The post hoc analysis of pooled data from the Semaglutide Treatment Effect in People with Obesity (STEP) 1, 2, 3, and 5 trials indicated that semaglutide treatment at 2.4 mg did not increase the risk of depressive symptoms or suicidal ideation compared to placebo, while demonstrating a statistically significant yet clinically negligible decrease in depressive symptoms [75]
Therefore, incorporating objective gut microbiome biomarkers represents best practice in the clinical setting to generate actionable insights
A little pricier than like
systematic review of 13 studies encompassing 84,065 patients demonstrated significantly higher retained gastric contents rates (odds ratio 5.56, 95% confidence interval 3.359.23) but found no significant difference in actual aspiration rates (odds ratio 1.75, 95% confidence interval 0.644.77) [37]